DR4 MEF, P2, untreated, 1 vial of 1
Order now: dominika@ksiazkiwnauce.pl
CORNING® UNTREATED MICROCARRIERS, 1 VIAL, 10 G |
|||
| 3772 | CORNING | 10g/pk | 117.6 EUR |
|
Description: Microcarriers; Corning Microcarriers |
|||
SNL 76/7 mouse fibroblast STO cell line, P12, untreated, 1 vials of 2^106 cells |
|||
| ASF-1305 | Applied StemCell | 1 vials of 2 x 10^6 cells | 95.92 EUR |
|
Description: 6 month |
|||
EZ-LINE Cell culture Dishes Untreated, 35X10mm, PS, Sterile untreated, 500 per case |
|||
| SP22146 | Bio Basic | 1CS, 500UNIT | 171 EUR |
HepG2 Cell Lysate, Untreated |
|||
| MBS657065-1Each | MyBiosource | 1Each | 465 EUR |
HepG2 Cell Lysate, Untreated |
|||
| MBS657065-5x1Each | MyBiosource | 5x1Each | 1940 EUR |
Jurkat cell Lysate (untreated) |
|||
| 2401-100 | Biovision | each | 222 EUR |
Rabbit Reticulocyte Lysate System (untreated) |
|||
| 20-abx800016 | Abbexa |
|
|
Rabbit Reticulocyte Lysate System (untreated) |
|||
| abx800016-10nmol | Abbexa | 10 nmol | 18125 EUR |
Rabbit Reticulocyte Lysate System (untreated) |
|||
| abx800016-5nmol | Abbexa | 5 nmol | 9375 EUR |
Custom Barcoded U96 Untreated Plate - 180 plates |
|||
| TH281615 | Westburg | each | Ask for price |
4 Well Dish Untreated Sterile With Lid - PK100 |
|||
| 267061 | Scientific Laboratory Supplies | PK100 | 1498.5 EUR |
Human FLL Bone Marrow Mononuclear Cells, Untreated |
|||
| ABC-TC3429 | AcceGen | 1 vial | Ask for price |
|
Description: FLL-Bone Marrow-Mononuclear Cells are obtained by density separation, using Ficoll-Paque to enrich the mononuclear cells. FLL-Bone Marrow-Mononuclear Cells are available in the untreated and relapsed/refractory samples. |
|||
EZ-LINE Cell culture Dishes Untreated, 150X20mm, 120 per case |
|||
| SP22260 | Bio Basic | 1CS, 120UNIT | 202.33 EUR |
EZ-LINE Cell culture Dishes Untreated, 150X25mm, 120 per case |
|||
| SP22261 | Bio Basic | 1CS, 120UNIT | 228.41 EUR |
75cm U-Shaped Untreated Vent Cap TC Flask - PK100 |
|||
| 431464U | Scientific Laboratory Supplies | PK100 | 333.45 EUR |
Human PV Peripheral Blood Mononuclear Cells (Untreated) |
|||
| ABC-TC4051 | AcceGen | 1 vial | Ask for price |
|
Description: PV Peripheral Blood Mononuclear Cells are enriched by separation using Ficoll-Paque density gradient from the peripheral blood. PV-PBMCs are available in untreated and relapsed/refractory stages. |
|||
Tricostatin A (TSA) Treated And Untreated Cell Lysates |
|||
| AACX2 | Cytoskeleton | 100 µg treated + 100 µg untreated | 107.12 EUR |
Human Multiple Myeloma PB Plasma (Newly Diagnosed/Untreated) |
|||
| ABC-TC3952 | AcceGen | 1 vial | Ask for price |
|
Description: Multiple Myeloma-PB-Plasma is obtained by centrifugation of Multiple Myeloma peripheral blood. Plasma has a diminished number of cells. Multiple Myeloma-PB-Plasma is available in both the newly diagnosed and relapsed/refractory stages. |
|||
EZ-LINE Cell culture Dishes Untreated, 60X15mm, 500 per case |
|||
| SP22171 | Bio Basic | 1CS, 500UNIT | 192.59 EUR |
EZ-LINE Cell culture Dishes Untreated, 90X15mm, 500 per case |
|||
| SP22201 | Bio Basic | 1CS, 500UNIT | 202.92 EUR |
Human Mantle Cell Lymphoma PB Plasma (Newly Diagnosed/Untreated) |
|||
| ABC-TC3891 | AcceGen | 1 vial | Ask for price |
|
Description: Mantle Cell Lymphoma-Plasma is obtained by centrifugation of blood tissues. Mantle Cell LymphomaPlasma is available in the untreated and relapsed/refractory stages. |
|||
Waldenstrom's Macroglobunemia Bone Marrow Mononuclear Cells, Untreated |
|||
| ABC-TC4274 | AcceGen | 1 vial | Ask for price |
|
Description: Waldenstrom's Macroglobunemia-Bone Marrow-Mononuclear Cells are density separated by Ficoll-Paque to enrich mononuclear cells from the bone marrow. Waldenstrom's Macroglobunemia-Bone Marrow-Mononuclear Cells are available in untreated and relapsed/refractory stages. |
|||
Human Acute Myeloid Leukemia PB Plasma (Newly Diagnosed/Untreated) |
|||
| ABC-TC3024 | AcceGen | 1 vial | Ask for price |
|
Description: Acute Myeloid Leukemia-PB-Plasma is obtained by centrifugation of Acute Myeloid Leukemia peripheral blood. Acute Myeloid Leukemia-PB-plasma has a diminished number of cells and platelets. Acute Myeloid Leukemia plasma is available in the newly diagnosed and relapsed/refractory stages. |
|||
Human Acute Lymphoid Leukemia PB Plasma (Newly Diagnosed/Untreated) |
|||
| ABC-TC3011 | AcceGen | 1 vial | Ask for price |
|
Description: Acute Lymphoid Leukemia-PB-Plasma is obtained by centrifugation of Acute Lymphoid Leukemia peripheral blood. This product has a diminished number of cells. Acute Lymphoid Leukemia-Plasma are available in the newly diagnosed and relapsed/refractory stages. |
|||
Human Chronic Lymphoid Leukemia PB Plasma (Newly Diagnosed/Untreated) |
|||
| ABC-TC3350 | AcceGen | 1 vial | Ask for price |
|
Description: Chronic Lymphoid Leukemia-PB Plasma is obtained by centrifugation of the Chronic Lymphoid Leukemia-PB-Mononuclear Cells. Plasma has a diminished number of cells and platelets. Chronic Lymphoid Leukemia plasma is available in untreated and relapsed/refractory stages. |
|||
Human Multiple Myeloma Bone Marrow Plasma (Newly Diagnosed/Untreated) |
|||
| ABC-TC3948 | AcceGen | 1 vial | Ask for price |
|
Description: Multiple Myeloma-Bone Marrow Plasma is obtained by centrifuging the Multiple Myeloma-bone marrow. The plasma has a diminished number of cells and platelets. Multiple Myeloma-Bone Marrow plasma is available in both the newly diagnosed and relapsed/refractory stages. |
|||
Acute Lymphoid Leukemia PB CD19+ B Cells (Newly Diagnosed/Untreated) |
|||
| ABC-TC3008 | AcceGen | 1 vial | Ask for price |
|
Description: Acute Lymphoid Leukemia-PB-CD19+ B cells are positively isolated from adult Acute Lymphoid Leukemia peripheral blood Mononuclear Cells, using a direct immunomagnetic CD19 MicroBead labeling system. Acute Lymphoid Leukemia-PB-CD19+ B cells are available in the newly diagnosed and relapsed/refractory stages. |
|||
Human Chronic Lymphoid Leukemia Bone Marrow CD19+ B Cells, Untreated |
|||
| ABC-TC3338 | AcceGen | 1 vial | Ask for price |
|
Description: Chronic Lymphoid Leukemia-Bone Marrow-CD19+ B Cells are isolated from Chronic Lymphoid Leukemia bone marrow mononuclear cells using a direct CD19+ system. They are available in untreated or relapsed/refractory stages. |
|||
Human Chronic Lymphoid Leukemia Peripheral Blood CD19+ B Cells, Untreated |
|||
| ABC-TC3353 | AcceGen | 1 vial | Ask for price |
|
Description: Chronic Lymphoid Leukemia-PB-CD19+ B cells are positively isolated from Chronic Lymphoid Leukemia peripheral blood Mononuclear Cells, using a direct immunomagnetic CD19 MicroBeads labeling system. Chronic Lymphoid Leukemia-CD19+ B cells are available in untreated and relapsed/refractory stages. |
|||
Human Mantle Cell Lymphoma Bone Marrow Plasma (Newly Diagnosed/Untreated) |
|||
| ABC-TC3887 | AcceGen | 1 vial | Ask for price |
|
Description: Mantle Cell Lymphoma-Plasma is obtained by centrifugation of blood tissues. Mantle Cell LymphomaPlasma is available in the untreated and relapsed/refractory stages. |
|||
Human Chronic Lymphoid Leukemia Bone Marrow CD19+/CD5+ B Cells, Untreated |
|||
| ABC-TC3341 | AcceGen | 1 vial | Ask for price |
|
Description: Chronic Lymphoid Leukemia-PB-CD19+/CD5+ B cells are isolated from Chronic Lymphoid Leukemia bone marrow mononuclear cells using a direct immunomagnetic CD19+ Micro- Bead labeling system. Available in untreated or relapsed/refractory stages.CD5 co-expression on Bone Marrow-CD19+ B Cells can be used as a strong indicator of Chronic Lymphoid Leukemia infiltration in the bone marrow. In many untreated or lower-staged Chronic Lymphoid Leukemia cases, the co-expression level of CD5 in Bone Marrow-CD19+ cells is significantly lower than the co-expression level within peripheral blood. |
|||
Human Diffuse Large B-Cell Lymphoma PB Plasma (Newly Diagnosed/Untreated) |
|||
| ABC-TC3407 | AcceGen | 1 vial | Ask for price |
|
Description: Diffuse Large B-Cell Lymphoma-PB-Plasma is obtained by centrifugation of peripheral blood tissue. Diffuse Large B-Cell Lymphoma Plasma is available in the untreated and relapsed/refractory stages. |
|||
Human Acute Lymphoid Leukemia Bone Marrow Plasma (Newly Diagnosed/Untreated) |
|||
| ABC-TC3006 | AcceGen | 1 vial | Ask for price |
|
Description: Acute Lymphoid Leukemia Bone Marrow plasma is obtained by centrifugation of the Acute Lymphoid Leukemia-bone marrow. This product has a diminished number of cells and platelets. Acute Lymphoid Leukemia plasma are available in the newly diagnosed and relapsed/refractory stages. |
|||
Human Acute Myeloid Leukemia Bone Marrow Plasma (Newly Diagnosed/Untreated) |
|||
| ABC-TC3019 | AcceGen | 1 vial | Ask for price |
|
Description: Acute Myeloid Leukemia-Bone Marrow Plasma is obtained by centrifugation of the adult Acute Myeloid LeukemiaBone Marrow. Plasma has a diminished number of cells and platelets. Acute Myeloid Leukemia plasma is available in the newly diagnosed and relapsed/refractory stages. |
|||
Human Chronic Lymphoid Leukemia Bone Marrow Plasma (Newly Diagnosed/Untreated) |
|||
| ABC-TC3344 | AcceGen | 1 vial | Ask for price |
|
Description: Chronic Lymphoid Leukemia Bone Marrow-Plasma is obtained by centrifugation of the Chronic Lymphoid Leukemia bone marrow. Plasma has a diminished number of cells and platelets. Chronic Lymphoid Leukemia plasma is available in untreated and relapsed/refractory stages. |
|||
Human Acute Myeloid Leukemia Bone Marrow CD34+ Cells (Newly Diagnosed/Untreated) |
|||
| ABC-TC3014 | AcceGen | 1 vial | Ask for price |
|
Description: Acute Myeloid Leukemia-Bone Marrow-CD34+ cells are selected from adult Acute Myeloid Leukemia-Bone Marrow-Mononuclear Cells. The Bone Marrow-CD34+ stem/progenitor cells are positively isolated using a direct immunomagnetic CD34 MicroBead labeling system. Acute Myeloid LeukemiaCD34+ cells are available in the newly diagnosed and relapsed/refractory stages. |
|||